Cargando…
Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review
BACKGROUND: As the remission rate of panic disorder (PD) achieved with conventional pharmacotherapy ranges between 20% and 50%, alternative psychopharmacological strategies are needed. We aimed to firstly review data regarding use of antipsychotic and non-benzodiazepine anticonvulsant medication in...
Autores principales: | Masdrakis, Vasilios G., Baldwin, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989133/ https://www.ncbi.nlm.nih.gov/pubmed/33815761 http://dx.doi.org/10.1177/20451253211002320 |
Ejemplares similares
-
Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008) -
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines
por: Perna, Giampaolo, et al.
Publicado: (2016) -
Pregabalin for the treatment of generalized anxiety disorder: an update
por: Baldwin, David S, et al.
Publicado: (2013) -
Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants
por: Baldwin, David S., et al.
Publicado: (2013) -
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2021)